| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.89B | 4.37B | 3.95B | 6.63B | 3.58B | 8.27B |
| Gross Profit | 2.62B | 2.01B | 336.00M | 6.57B | 3.07B | 697.00M |
| EBITDA | 1.31B | 574.00M | -1.32B | 4.88B | 2.17B | -1.24B |
| Net Income | 967.00M | 388.00M | -1.11B | 3.88B | 1.64B | -1.06B |
Balance Sheet | ||||||
| Total Assets | 244.68B | 238.54B | 236.34B | 225.72B | 259.84B | 247.87B |
| Cash, Cash Equivalents and Short-Term Investments | 88.14B | 86.97B | 86.01B | 80.77B | 94.00B | 89.84B |
| Total Debt | 3.15B | 3.15B | 3.16B | 3.16B | 3.16B | 3.44B |
| Total Liabilities | 238.25B | 233.51B | 231.33B | 220.19B | 243.63B | 229.78B |
| Stockholders Equity | 6.36B | 4.96B | 4.94B | 5.46B | 16.14B | 18.02B |
Cash Flow | ||||||
| Free Cash Flow | 144.00M | -290.00M | -137.00M | -1.23B | 746.00M | 888.00M |
| Operating Cash Flow | 144.00M | -290.00M | -137.00M | -1.23B | 746.00M | 888.00M |
| Investing Cash Flow | 1.69B | -2.19B | -3.20B | -8.28B | -12.24B | -5.84B |
| Financing Cash Flow | -858.00M | 3.68B | 3.07B | 9.14B | 11.86B | 6.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $3.75B | 4.48 | 16.27% | ― | 27.71% | ― | |
74 Outperform | $4.07B | 9.08 | 10.12% | 2.91% | -4.58% | ― | |
72 Outperform | $3.93B | 14.42 | 11.12% | 1.60% | -1.61% | 15.79% | |
70 Outperform | $7.58B | 3.55 | 21.66% | 4.39% | 35.76% | 636.97% | |
69 Neutral | $6.29B | 12.65 | 5.50% | 3.36% | 24.94% | ― | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
60 Neutral | $3.50B | 19.28 | 2.86% | ― | 1.41% | 150.35% |
On November 6, 2025, Brighthouse Financial announced a merger agreement with Aquarian Holdings, where it will become a wholly-owned subsidiary of Aquarian. This strategic move aims to enhance Brighthouse Financial’s growth opportunities and asset-generation capabilities, positioning it better in the evolving insurance market. The merger, expected to close in 2026, will maintain Brighthouse Financial’s operations as a standalone entity within Aquarian’s portfolio, with no immediate changes to its current operations or employee roles.
The most recent analyst rating on (BHF) stock is a Hold with a $70.00 price target. To see the full list of analyst forecasts on Brighthouse Financial stock, see the BHF Stock Forecast page.
On November 6, 2025, Brighthouse Financial, Inc. announced a merger agreement with Aquarian Holdings, where Aquarian will acquire Brighthouse for $70 per share in cash. The merger, which has been unanimously approved by Brighthouse’s Board of Directors, is subject to customary closing conditions, including regulatory approvals and stockholder approval. The merger aims to enhance Brighthouse’s market position and operational capabilities, with implications for stockholders in terms of share conversion and cash payments. The transaction is expected to close by December 6, 2026, if all conditions are met.
The most recent analyst rating on (BHF) stock is a Hold with a $61.00 price target. To see the full list of analyst forecasts on Brighthouse Financial stock, see the BHF Stock Forecast page.
On August 27, 2025, Brighthouse Financial announced the appointment of Myles J. Lambert as Executive Vice President and Chief Operating Officer, effective August 30, 2025. Lambert, who has been with the company since 2017, will continue to lead distribution and marketing while overseeing operations. Additionally, Melissa Pavlovich was appointed as Chief Accounting Officer, succeeding Richard Cook, who will now serve as Deputy CAO. These leadership changes are expected to enhance the company’s strategic direction and operational efficiency.
The most recent analyst rating on (BHF) stock is a Hold with a $48.00 price target. To see the full list of analyst forecasts on Brighthouse Financial stock, see the BHF Stock Forecast page.
Brighthouse Financial’s recent earnings call painted a mixed picture of the company’s performance. While there was notable growth in sales and a robust capital and liquidity position, the company faced headwinds with lower adjusted earnings and a decline in the combined RBC ratio. Challenges were further compounded by a drop in alternative investment income and adverse non-VA results.